Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +0.61% | +2.40% | +33.26% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.26% | 2.37B | |
+11.94% | 3,129B | |
+10.56% | 86.84B | |
+6.08% | 78.63B | |
-14.95% | 53.93B | |
+26.21% | 48.21B | |
-23.40% | 47.43B | |
+29.50% | 45.58B | |
+76.40% | 41.03B | |
-9.24% | 24.92B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI Shares Rise After William Blair Upgrades Stock to Outperform From Market Perform